Follow us!
Innovation
Knowledge
Leadership
Competence
Credibility
ISPUP
  • Home
  • Research
  • Projects
  • An open labeled randomized controlled pragmatic trial to evaluate the efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia.

An open labeled randomized controlled pragmatic trial to evaluate the efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia.

André Moreira

Principal Investigator

Integrated Member (PhD)

Type of project:

National

Reference:

no ref

Participating institutions:

CHUSJ; FMUP.

Sources of financing:

Support Research 4 Covid-19 - FCT

Start date:

05/05/2020

(Predicted) End date:

05/03/2021

Total budget:

30.000,00 €

Research line:

L4 - Patient and Population Outcomes Research

Research lab:

Epidemiology of Allergic Conditions

Summary:

 

 

Research team

Milton Severo
Milton Severo Integrated Member (PhD)
Mariana Farraia
Mariana Farraia Integrated Member (Non-PhD)
Inês Paciência
Inês Paciência Collaborator